The city has reached a $54 million settlement with two opioid manufacturers, Allergen and Teva, the City Attorney’s Office announced Tuesday.
Under the terms of the agreement, the companies will pay $34 million in cash payments that will go to “opioid abatement and overdose prevention” and will provide a $20 million supply of Narcan, an opioid antidote.
That brings the total San Francisco has accrued so far in such settlements to $120 million.
“Under this agreement, our City will receive significant resources to combat the opioid crisis and bring relief to our communities,” City Attorney David Chiu said in a statement. “We look forward to presenting closing arguments in our trial against the remaining defendant, Walgreens, to make sure they are also held accountable for the crisis they fueled.”